- Home
- JPI vs TCMD Comparison
JPI vs TCMD Comparison
Compare JPI & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JPI
- TCMD
- Stock Information
- Founded
- JPI 2012
- TCMD 1995
- Country
- JPI United States
- TCMD United States
- Employees
- JPI N/A
- TCMD N/A
- Industry
- JPI Finance Companies
- TCMD Medical/Dental Instruments
- Sector
- JPI Finance
- TCMD Health Care
- Exchange
- JPI Nasdaq
- TCMD Nasdaq
- Market Cap
- JPI 288.1M
- TCMD 300.1M
- IPO Year
- JPI N/A
- TCMD 2016
- Fundamental
- Price
- JPI $20.70
- TCMD $13.51
- Analyst Decision
- JPI
- TCMD Hold
- Analyst Count
- JPI 0
- TCMD 3
- Target Price
- JPI N/A
- TCMD $13.50
- AVG Volume (30 Days)
- JPI 54.7K
- TCMD 182.1K
- Earning Date
- JPI 01-01-0001
- TCMD 11-03-2025
- Dividend Yield
- JPI 6.15%
- TCMD N/A
- EPS Growth
- JPI N/A
- TCMD N/A
- EPS
- JPI N/A
- TCMD 0.63
- Revenue
- JPI N/A
- TCMD $298,851,000.00
- Revenue This Year
- JPI N/A
- TCMD $8.85
- Revenue Next Year
- JPI N/A
- TCMD $8.24
- P/E Ratio
- JPI N/A
- TCMD $21.75
- Revenue Growth
- JPI N/A
- TCMD 6.15
- 52 Week Low
- JPI $16.02
- TCMD $8.61
- 52 Week High
- JPI $19.12
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- JPI 66.91
- TCMD 61.29
- Support Level
- JPI $20.15
- TCMD $13.14
- Resistance Level
- JPI $20.70
- TCMD $13.73
- Average True Range (ATR)
- JPI 0.15
- TCMD 0.37
- MACD
- JPI 0.05
- TCMD -0.06
- Stochastic Oscillator
- JPI 93.22
- TCMD 70.00
About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest
Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.